Advanced age impairs cardioprotective function of mesenchymal stem cell transplantation from patients to myocardially infarcted rats

Cardiology (Switzerland)

Volumn 128, Issue 2, 2014, Pages 209-219

  Liu, Yu ^a,b   Liu, Tao ^a   Han, Jinsong ^a,b   Yang, Zhonglu ^a   Xue, Xiaodong ^a   Jiang, Hui ^a   Wang, Huishan ^a  

^a Shenyang Northern Hospital   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Advanced age; Coronary artery disease; Mesenchymal stem cells; Myocardial infarction

Indexed keywords

MESSENGER RNA; PROTEIN BCL 2; VASCULOTROPIN; VASCULOTROPIN A;

ADULT; AGE; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CAPILLARY DENSITY; CELL GROWTH; CELL ISOLATION; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CULTURE MEDIUM; ECHOCARDIOGRAPHY; GENE EXPRESSION; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE; HEART PROTECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MALE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; NICK END LABELING; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; WESTERN BLOTTING; ANIMAL; CELL CULTURE; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RANDOMIZATION; ANIMAL CELL; ANIMAL TISSUE; CLINICAL ARTICLE;

ADULT; AGE FACTORS; AGED; ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; PHENOTYPE; PROTO-ONCOGENE PROTEINS C-BCL-2; RANDOM ALLOCATION; RATS; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84899776263     PISSN: 00086312     EISSN: 14219751     Source Type: Journal    
DOI: 10.1159/000360393     Document Type: Article

References (41)

1. Okrainec K, Banerjee D, Eisenberg M: Coronary artery disease in the devleoping world. Am Heart J 2004; 1: 7-15. (Pubitemid 38900475)
2. Zhang XH, Lu ZL, Liu L: Coronary heart disease in China. Heart 2008; 94: 1126-1131.
3. Boilson BA, Gulati R: Stem cell therapy for the heart: a perspective. Transl Res 2010; 155: 3-5.
4. Quevedo HC, Hatzistergos KE, Oskouei BN, Feigenbaum GS, Rodriguez JE, Valdes D, Pattany PM, Zambrano JP, Hu Q, McNiece I, Heldman AW, Hare JM: Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic cardiomyopathy via trilineage differentiating capacity. Proc Natl Acad Sci USA 2009; 106: 14022-14027.
5. Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E: Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 2006; 8: 315-317. (Pubitemid 44269669)
6. Sethe S, Scutt A, Stolzing A: Aging of mesenchymal stem cells. Ageing Res Rev 2006; 5: 91-116. (Pubitemid 43139669)
7. Krause U, Harter C, Seckinger A, Wolf D, Reinhard A, Bea F, Dengler T, Hardt S, Ho A, Katus HA, Kuecherer H, Hansen A: Intravenous delivery of autologous mesenchymal stem cells limits infarct size and improves left ventricular function in the infarcted porcine heart. Stem Cells Dev 2007; 16: 31-37. (Pubitemid 46362590)
8. Caplan AI, Dennis JE: Mesenchymal stem cells as trophic mediators. J Cell Biochem 2006; 98: 1076-1084. (Pubitemid 44128350)
9. Wang M, Crisostomo PR, Herring C, Meldrum KK, Meldrum DR: Human progenitor cells from bone marrow or adipose tissue produce VEGF, HGF, and IGF-I in response to TNF by a p38 MAPK-dependent mechanism. Am J Physiol Regul Integr Comp Physiol 2006; 291:R880-R884. (Pubitemid 44498426)
10. Kupatt C, Horstkotte J, Vlastos GA, Pfosser A, Lebherz C, Semisch M, Thalgott M, Buttner K, Browarzyk C, Mages J, Hoffmann R, Deten A, Lamparter M, Muller F, Beck H, Buning H, Boekstegers P, Hatzopoulos AK: Embryonic endothelial progenitor cells expressing a broad range of proangiogenic and remodeling factors enhance vascularization and tissue recovery in acute and chronic ischemia. FASEB J 2005; 19: 1576-1578. (Pubitemid 41279036)
11. Gnecchi M, Zhang Z, Ni A, Dzau VJ: Paracrine mechanisms in adult stem cell signaling and therapy. Circ Res 2008; 103: 1204-1219.
12. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS, Hermiller JJ, Reisman MA, Schaer GL, Sherman W: A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009; 54: 2277-2286.
13. Cui X, Wang H, Guo H, Wang C, Ao H, Liu X, Tan YZ: Transplantation of mesenchymal stem cells preconditioned with diazoxide, a mitochondrial ATP-sensitive potassium channel opener, promotes repair of myocardial infarction in rats. Tohoku J Exp Med 2010; 220: 139-147.
14. Jin P, Zhang X, Wu Y, Li L, Yin Q, Zheng L, Zhang H, Sun C: Streptozotocin-induced diabetic rat-derived bone marrow mesenchymal stem cells have impaired abilities in proliferation, paracrine, antiapoptosis, and myogenic differentiation. Transplant Proc 2010; 42: 2745-2752.
15. Hou M, Yang KM, Zhang H, Zhu WQ, Duan FJ, Wang H, Song YH, Wei YJ, Hu SS: Transplantation of mesenchymal stem cells from human bone marrow improves damaged heart function in rats. Int J Cardiol 2007; 115: 220-228. (Pubitemid 46157045)
16. Fan M, Chen W, Liu W, Du GQ, Jiang SL, Tian WC, Sun L, Li RK, Tian H: The effect of age on the efficacy of human mesenchymal stem cell transplantation after a myocardial infarction. Rejuvenation Res 2010; 13: 429-438.
17. Dimmeler S, Leri A: Aging and disease as modifiers of efficacy of cell therapy. Circ Res 2008; 102: 1319-1330.
18. Liu Y, Li Z, Liu T, Xue X, Jiang H, Huang J, Wang H: Impaired cardioprotective function of transplantation of mesenchymal stem cells from patients with diabetes mellitus to rats with experimentally induced myocardial infarction. Cardiovasc Diabetol 2013; 12: 40.
19. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM: Identification of mesenchymal stem/progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 2001; 98: 2396-2402.
20. Brunner S, Theiss HD, Leiss M, Grabmaier U, Grabmeier J, Huber B, Vallaster M, Clevert DA, Sauter M, Kandolf R, Rimmbach C, David R, Klingel K, Franz WM: Enhanced stem cell migration mediated by VCAM-1/VLA-4 interaction improves cardiac function in virus-induced dilated cardiomyopathy. Basic Res Cardiol 2013; 108: 388.
21. Piegari E, De Angelis A, Cappetta D, Russo R, Esposito G, Costantino S, Graiani G, Frati C, Prezioso L, Berrino L, Urbanek K, Quaini F, Rossi F: Doxorubicin induces senescence and impairs function of human cardiac progenitor cells. Basic Res Cardiol 2013; 108: 334.
22. Sakaguchi G, Tambara K, Sakakibara Y, Ozeki M, Yamamoto M, Premaratne G, Lin X, Hasegawa K, Tabata Y, Nishimura K, Komeda M: Control-released hepatocyte growth factor prevents the progression of heart failure in stroke-prone spontaneously hypertensive rats. Ann Thorac Surg 2005; 79: 1627-1634. (Pubitemid 40614578)
23. Fadini GP, Albiero M, Seeger F, Poncina N, Menegazzo L, Angelini A, Castellani C, Thiene G, Agostini C, Cappellari R, Boscaro E, Zeiher A, Dimmeler S, Avogaro A: Stem cell compartmentalization in diabetes and high cardiovascular risk reveals the role of DPP-4 in diabetic stem cell mobilopathy. Basic Res Cardiol 2013; 108: 313.
24. Boengler K, Schulz R, Heusch G: Loss of cardioprotection with ageing. Cardiovasc Res 2009; 83: 247-261.
25. Gao J, Dennis JE, Muzic RF, Lundberg M, Caplan AI: The dynamic in vivo distribution of bone marrow-derived mesenchymal stem cells after infusion. Cells Tissues Organs 2001; 169: 12-20. (Pubitemid 32437040)
26. Tokalov SV, Gruner S, Schindler S, Wolf G, Baumann M, Abolmaali N: Age-related changes in the frequency of mesenchymal stem cells in the bone marrow of rats. Stem Cells Dev 2007; 16: 439-446. (Pubitemid 47016229)
27. Bonnefoy-Berard N, Aouacheria A, Verschelde C, Quemeneur L, Marcais A, Marvel J: Control of proliferation by Bcl-2 family members. Biochim Biophys Acta 2004; 1644: 159-168. (Pubitemid 38281272)
28. Deissler H, Deissler H, Lang S, Lang GE: VEGFinduced effects on proliferation, migration and tight junctions are restored by ranibizumab (Lucentis) in microvascular retinal endothelial cells. Br J Ophthalmol 2008; 92: 839-843. (Pubitemid 351839580)
29. Ferrara N: Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. Semin Oncol 2002; 29: 10-14.
30. Xu XH, Xu J, Xue L, Cao HL, Liu X, Chen YJ: VEGF attenuates development from cardiac hypertrophy to heart failure after aortic stenosis through mitochondrial mediated apoptosis and cardiomyocyte proliferation. J Cardiothorac Surg 2011; 6: 54.
31. Gross A, McDonnell JM, Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 1999; 13: 1899-1911. (Pubitemid 29407357)
32. Willis S, Day CL, Hinds MG, Huang DC: The Bcl-2-regulated apoptotic pathway. J Cell Sci 2003; 116: 4053-4056. (Pubitemid 37337079)
33. Atoui R, Shum-Tim D, Chiu RC: Myocardial regenerative therapy: immunologic basis for the potential 'universal donor cells'. Ann Thorac Surg 2008; 86: 327-334.
34. Nauta AJ, Fibbe WE: Immunomodulatory properties of mesenchymal stromal cells. Blood 2007; 110: 3499-3506. (Pubitemid 350159613)
35. Lim WY, Messow CM, Berry C: Cyclosporin variably and inconsistently reduces infarct size in experimental models of reperfused myocardial infarction: a systematic review and meta-analysis. Br J Pharmacol 2012; 165: 2034-2043.
36. Skyschally A, Schulz R, Heusch G: Cyclosporine A at reperfusion reduces infarct size in pigs. Cardiovasc Drugs Ther 2010; 24: 85-87.
37. Liang H, Hou H, Yi W, Yang G, Gu C, Lau WB, Gao E, Ma X, Lu Z, Wei X, Pei J, Yi D: Increased expression of pigment epitheliumderived factor in aged mesenchymal stem cells impairs their therapeutic efficacy for attenuating myocardial infarction injury. Eur Heart J 2013; 34: 1681-1690.
38. Nakamura M, Yamabe H, Osawa H, Nakamura N, Shimada M, Kumasaka R, Murakami R, Fujita T, Osanai T, Okumura K: Hypoxic conditions stimulate the production of angiogenin and vascular endothelial growth factor by human renal proximal tubular epithelial cells in culture. Nephrol Dial Transplant 2006; 21: 1489-1495. (Pubitemid 44063122)
39. Li W, Ma N, Ong LL, Nesselmann C, Klopsch C, Ladilov Y, Furlani D, Piechaczek C, Moebius JM, Lutzow K, Lendlein A, Stamm C, Li RK, Steinhoff G: Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 2007; 25: 2118-2127. (Pubitemid 47258191)
40. Fan W, Crawford R, Xiao Y: The ratio of VEGF/PEDF expression in bone marrow mesenchymal stem cells regulates neovascularization. Differentiation 2011; 81: 181-191.
41. Zhang Z, Li S, Cui M, Gao X, Sun D, Qin X, Narsinh K, Li C, Jia H, Li C, Han Y, Wang H, Cao F: Rosuvastatin enhances the therapeutic efficacy of adipose-derived mesenchymal stem cells for myocardial infarction via PI3K/Akt and MEK/ERK pathways. Basic Res Cardiol 2013; 108: 333.